Mid Atlantic Headache Institute is a clinical research site located in Pikesville, Maryland, United States 21208.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Mid Atlantic Headache Institute has participated in 1 clinical trials.
Therapeutic areas: Partial Seizures, Epilepsies, Partial.
Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc..
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Mid Atlantic Headache Institute has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mid Atlantic Headache Institute has 1 clinical trials on record. Their work covers Partial Seizures, Epilepsies, Partial.
Mid Atlantic Headache Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.